Poor prediction of potentially drug-resistant pathogens using current criteria of health care-associated pneumonia

Respiratory Medicine
Seon Cheol ParkJi Ye Jung

Abstract

Health care-associated pneumonia (HCAP) includes a broad range of patients having frequent or chronic contact with health care systems. However, the relationship between current defining criteria for HCAP and the risk of potentially drug-resistant (PDR) pathogens is controversial. We retrospectively evaluated patients admitted to Severance Hospital in South Korea with culture-positive pneumonia from January 2008 to December 2009. We analyzed the associations between risk factors for HCAP and infection with PDR pathogens, and developed a new scoring system to predict infection with PDR pathogens. Among 339 patients, PDR pathogens were observed in 122 (36.0%). PDR pathogens were more common in HCAP than community-acquired pneumonia (CAP) (48.5% versus 23.8%, P<0.001). In a logistic regression, prior hospitalization within 90 days of pneumonia (OR=2.51, P=0.003), recent treatment with antimicrobials (OR=2.35, P=0.039), and nasogastric tube feeding (OR=15.28, P<0.001) were independently associated with PDR pathogens. For the prediction of PDR pathogens, the sensitivity and specificity of current HCAP criteria were 66.4% and 60.4%, respectively, and 68.0% and 67.3%, respectively, for the new scoring system. Moreover, the new scoring...Continue Reading

References

Feb 26, 1998·American Journal of Respiratory and Critical Care Medicine·J L TrouilletC Gibert
Oct 13, 2000·American Journal of Respiratory and Critical Care Medicine·M C PasteurM T Keogan
Feb 9, 2005·American Journal of Respiratory and Critical Care Medicine·UNKNOWN American Thoracic Society, UNKNOWN Infectious Diseases Society of America
Aug 8, 2007·Antimicrobial Agents and Chemotherapy·Scott T MicekMarin H Kollef
Jan 7, 2009·Annals of Internal Medicine·Mario VendittiUNKNOWN Study Group of the Italian Society of Internal Medicine
Jul 8, 2010·Respiratory Medicine·Hye Kyeong ParkKyeongman Jeon
Jan 29, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Diego ViasusJordi Carratalà
Mar 15, 2011·BMC Infectious Diseases·Ji Ye JungYoung Ae Kang
Mar 26, 2011·The European Respiratory Journal·R T AttridgeE M Mortensen
Jun 15, 2011·The American Journal of Medicine·Russell T Attridge, Christopher R Frei
Jun 22, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James D ChalmersAdam T Hill
Oct 12, 2011·Immunological Investigations·David A Stevens, George L Melikian

❮ Previous
Next ❯

Citations

Jan 10, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Giovanna Fabio, Maria Carrabba
Dec 20, 2015·Respirology : Official Journal of the Asian Pacific Society of Respirology·Mark L MeterskyEric M Mortensen
Mar 26, 2014·Respirology : Official Journal of the Asian Pacific Society of Respirology·Hon Ming MaDavid S C Hui
Dec 4, 2014·Respiratory Medicine·Brandon J WebbNathan Dean
Jul 23, 2016·International Journal of Antimicrobial Agents·Sheng-Feng HuangYing-Chi Lin
Aug 6, 2017·Respirology : Official Journal of the Asian Pacific Society of Respirology·Yuichiro Shindo, Yoshinori Hasegawa
Mar 10, 2016·Current Opinion in Pulmonary Medicine·Oriol SibilaMarcos I Restrepo
Apr 22, 2020·Antimicrobial Agents and Chemotherapy·Courtney HebertErinn M Hade
Jul 7, 2018·Journal of Clinical Microbiology·Stefan E RichterJames A McKinnell
Feb 18, 2016·Current Opinion in Infectious Diseases·Brandon J WebbNathan C Dean
May 29, 2015·Clinical Microbiology Reviews·Steven Y C TongVance G Fowler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

The European Respiratory Journal
Russell T AttridgeE M Mortensen
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Diego ViasusJordi Carratalà
Annals of Internal Medicine
Mario VendittiStudy Group of the Italian Society of Internal Medicine
Current Opinion in Pulmonary Medicine
Marya D Zilberberg, Andrew Shorr
© 2021 Meta ULC. All rights reserved